BELLEVUE, Wash.--(BUSINESS WIRE)--SCOLR Pharma, Inc. (AMEX: DDD) today announced that Jeff Reich, M.D. and Greg Weaver, CPA, M.B.A have been appointed to the Company's Board of Directors.
Michael N. Taglich, Chairman of SCOLR Pharma’s Board of Directors, said, “Jeff and Greg are two experienced healthcare professionals with proven leadership skills and track records for building successful businesses. Jeff’s knowledge of the healthcare industry coupled with his clinical expertise will be a valuable asset as our business continues to grow and evolve. Greg brings a great deal of healthcare, finance and audit experience to our Board. His significant business development experience with bio-pharmaceutical companies will be extremely valuable as we continue to broaden our product pipeline and seek additional partnering opportunities. With our recent addition to the board of Bruce S. Morra, Ph.D., M.B.A, a seasoned healthcare executive, we are very pleased to be adding these two healthcare veterans that will complement the collective experience of our existing board members.”
